Strong Insecticide Fenbendazole Suspension
Customizable Branded Acrylic Display
Antiviral Versatile Powder Chinese Herbs
Premium Egg-Based Vaccine Innovations
High Quality Poultry Antibacterial Drugs
Toltrazuril Oral Solution 2.5% 5%
Liquid Calcium Supplement for Pets
Pharmaceutical 96% Ivermectin Powder
Anthelmintics, the class of drugs used to treat infections caused by parasitic worms (helminths), remain a cornerstone of global public health and animal husbandry. As the world faces an increasing demand for protein, the livestock industry—including cattle, swine, and poultry—is under pressure to maintain high health standards. Helminth infections are not merely a welfare issue; they cause significant economic losses through reduced growth rates, decreased milk production, and high mortality in young animals.
In the commercial sector, the global anthelmintic market is projected to grow significantly, driven by the expansion of large-scale farming in emerging economies and the surging pet ownership in urban centers. Today, anthelmintics are no longer just simple dewormers; they are sophisticated pharmaceutical agents designed for targeted delivery, minimal environmental impact, and reduced withdrawal periods.
The industry is currently shifting toward "Combination Therapies" and "Slow-Release Technologies." As parasite resistance becomes a growing concern worldwide, manufacturers are focused on developing dual-action formulas that combine different chemical classes, such as macrocyclic lactones with benzimidazoles, to ensure efficacy.
Furthermore, there is a rising demand for specialized formulations like oral suspensions and spot-on treatments for pets. The integration of AI in drug discovery has allowed manufacturers like Hangzhou Jeci Biochem to simulate drug-receptor interactions, significantly shortening the development cycle for next-generation anthelmintic compounds.
From the vast cattle ranches of Brazil to the intensive poultry farms in Southeast Asia, the requirement for reliable anthelmintics is universal yet context-specific. Procurement officers are now looking beyond just "price per kilogram." They require documentation of purity (API standards), stability data for tropical climates, and supply chain transparency.
High-volume requirements for bulk powders and feed additives to maintain herd health in high-density environments.
Demand for palatable, easy-to-administer liquid or tablet forms with high safety margins for domestic cats and dogs.
Global labs sourcing high-purity raw materials (96%+ purity) for localized formulation and branding.
China has solidified its position as the global hub for pharmaceutical manufacturing. As a leading manufacturer and supplier, Hangzhou Jeci Biochem offers an unparalleled blend of cost-efficiency and high-tech R&D. Our localized presence in Hangzhou allows us to tap into a massive talent pool of biochemists and a robust logistical network.
Our competitive edge lies in our Integrated Supply Chain. We don't just sell products; we provide custom manufacturing services that allow international buyers to request specific concentrations, packaging sizes, and even proprietary formulations that meet the regulatory standards of their home countries (FDA, EMA, or local ministries).
Our drugs and intermediates are engineered for versatility across multiple sectors:
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization.
For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
Our anthelmintic range covers broad-spectrum activities against gastrointestinal nematodes, lungworms, and ectoparasites. For instance, the mechanism of Ivermectin involves increasing the permeability of the parasite cell membrane to chloride ions, leading to hyperpolarization and paralysis. By providing 96% pure pharmaceutical-grade powder, we ensure that the final deworming medications produced by our partners have the highest possible bioavailability.
Similarly, our Fenbendazole solutions work by inhibiting the polymerization of tubulin into microtubules, effectively starving the parasites of glucose. These mechanisms are researched extensively in our collaborative labs to ensure that they are safe for the host animal while being lethal to the target pathogen. This scientific rigor is what makes Hangzhou Jeci Biochem a preferred supplier for international pharmaceutical brands.
Every batch undergoes rigorous HPLC testing to ensure chemical stability and purity, meeting global pharmaceutical standards.
We provide comprehensive dossiers and technical data sheets (TDS) to assist our clients with local product registration processes.
Our R&D team can modify existing molecules to create proprietary intermediates, giving your brand a unique competitive edge.
We understand that the veterinary market in India differs significantly from that in South Korea or Japan. That's why we offer "Exclusive Regional Agency" opportunities. By partnering with us, you gain access to our technology transfer services, allowing you to manufacture high-demand anthelmintics locally while relying on our stable supply of active ingredients and technological expertise.
SJ medical
